Table 1 Maximum likelihood estimates for the models for IgG S1-RBD, after excluding days post-onset of symptom variable.
From: SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests
Parameter | Estimate | 95% confidence interval |
|---|---|---|
\({\alpha }\) | 5.317 | (4.35, 6.285) |
\({\beta }\) | 0.187 | (0.112, 0.262) |
\({\sigma }\) | 3277.827 | (846.694, 12,689.540) |
